We follow scientific evidence as much as possible, and try to be both practical and somewhat conservative. We try to pay attention to a patient’s particular concerns and we feel it’s very important to explain to patients and their families why a certain diagnosis is made, and why particular treatments are chosen, and it’s equally important to educate people about the diseases we work with. We try to avoid doing unnecessary testing or giving medicines that aren’t likely to be helpful, and hope to focus on improving quality of life as much as possible.

Baptist Health Memory Clinic-North Little Rock is now offering an innovative infusion treatment approved by the Federal Drug Administration (FDA) for certain people in the early stages of Alzheimer’s disease. In a large, 18-month study, intravenous (IV) infusion treatment with LEQEMBI was proven to slow the progression of early Alzheimer’s disease, helping people remember, solve problems, and complete daily activities for longer. LEQEMBI is for people who are experiencing: 

• Mild cognitive impairment (MCI) due to Alzheimer’s disease. This is when symptoms like forgetfulness and confusion are very mild and may not get in the way of daily life. 
• Mild Alzheimer’s dementia. This is when symptoms like trouble keeping track of bills and difficulty with familiar tasks start to get in the way of daily life.